Partner
120 South Riverside Plaza, Suite 2200
Chicago, Illinois
60606
+13125261546
Patent star 2023
English
Patent litigation
Regulatory
Biotechnology
Life sciences
Pharmaceutical
Don has extensive experience at the trial and appellate level litigating Hatch-Waxman statutory patent infringement and other actions involving prescription pharmaceutical drugs. These include Wellbutrin XL (bupropion), Intuniv (guanfacine), Megace ES (megestrol acetate), Dexilant (dexlansoprazole), Oxtellar XR (oxcarbazepine), Lidoderm (lidocaine), Ambien CR (zolpidem), Letairis (ambrisentan), Intermezzo (zolpidem), Livalo (pitavastatin), Strattera (atomoxetine), Androgel (testosterone), Axiron (testosterone), Restasis (cyclosporine), Adderall XR (mixed amphetamine salts), Clarinex (desloratadine), Amrix (cyclobenzaprine), Enablex (darifenacin), Cymbalta (duloxetine), Eliquis (apixaban), Luvox CR (fluvoxamine), Ryzolt (tramadol), Keppra XR (levetiracetam), Mirapex ER (pramipexole), Requip XL (ropinirole), and Wellbutrin SR/Zyban (bupropion). Among Don’s considerable patent litigation forums are injunction hearings, Markman proceedings, trials, and appeals. He has represented clients in patent cases involving a wide range of technologies, including pharmaceuticals, aluminum alloys, silicon on insulator manufacturing, computer software and ergonomic computer accessories.
Before joining the firm, Don was Chief Assistant State’s Attorney in the Cook County State’s Attorney’s Office.
Education/Alumni: